Cardinal Health to Acquire AdaptHealth Diabetes Unit and Strive Medical for $360 Million

Cardinal Health has signed an agreement to acquire AdaptHealth's diabetes unit and Strive Medical for a total of $360 million. According to Reuters, the acquisition aims to strengthen the company's presence in diabetes management. Under the deal, Cardinal Health will take over AdaptHealth's diabetes products and services division. Additionally, Strive Medical's assets are included in the acquisition package. This move is seen as part of the company's growth strategy. The acquisition is expected to close in the first quarter of 2024, pending regulatory approvals. With this step, Cardinal Health aims to increase its share in the diabetes care market and offer patient-focused solutions. This is not investment advice.

📊 GOOGL — Piyasa Yorumu

■ neutral · 30%

The news concerns a health sector acquisition that does not directly affect GOOGL. Technical indicators are weak: the price is below the SMA20 and SMA50, the RSI at 41 is near the sell zone, and the MACD is below the signal line and negative. A 6.3% decline in the last 24 hours confirms short-term pressure. However, as the news impact is limited, directional uncertainty remains high.

RSI 14

41.2

MACD

-2.60

24h Δ

-6.29%

📊 CAH — Piyasa Yorumu

▲ up · 60%

The news indicates that the company has made a significant acquisition in the diabetes and medical device sector as part of its growth strategy. Technical indicators show the RSI at 39.5, near oversold territory, and the price is below the 20-day moving average, suggesting potential for a short-term recovery. Although the MACD line is below the signal line, the acquisition news could act as a positive catalyst to lift the price. However, momentum remains weak, so the upside may be limited.

RSI 14

39.5

MACD

-0.99

24h Δ

0.16%

Canlı Grafikler